Treatment of Incontinence Without Memory Problems (TRIUMPH)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 20 Sep 2017
At a glance
- Drugs Mirabegron (Primary) ; Tolterodine
- Indications Urinary incontinence
- Focus Therapeutic Use
- Acronyms TRIUMPH
- 15 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 24 Oct 2016 Planned End Date changed from 1 Jul 2017 to 1 Jul 2018.
- 24 Oct 2016 Planned primary completion date changed from 1 Jan 2017 to 1 Dec 2017.